Loading clinical trials...
Loading clinical trials...
The Impact of Lifestyle Redesign Program in Schizophrenia
This study aimed to investigate the effects of lifestyle redesign program plus treatment as usual versus treatment as usual on cognition, psychiatric symptoms, quality of life, and occupational engagement for schizophrenia.
Age
20 - 65 years
Sex
ALL
Healthy Volunteers
No
Start Date
July 1, 2020
Primary Completion Date
November 30, 2020
Completion Date
November 30, 2020
Last Updated
June 12, 2020
30
ESTIMATED participants
lifestyle redesign program
BEHAVIORAL
Lead Sponsor
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
NCT07485530
NCT07450274
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06505109